单位：[1]China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China[2]Shanghai Univ TCM, Longhua Hosp, Dept Nephrol, Shanghai, Peoples R China[3]Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China[4]China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China[5]Hebei United Univ, Res Ctr Expt Med, Tangshan, Peoples R China[6]Hebei United Univ, Affiliated Hosp, Dept Endocrinol, Tangshan, Peoples R China[7]Beijing Univ Chinese Med, Dongzhimen Hosp, Dept Nephrol, Beijing, Peoples R China[8]Tangshan Gongren Hosp, Dept Endocrinol, Tangshan, Peoples R China[9]Kailuan Gen Hosp, Dept Endocrinol, Tangshan, Peoples R China[10]China Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China
第一作者单位：[1]China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Li Ping,Chen Yiping,Liu Jianping,et al.EFFECTS OF TANGSHEN FORMULA ON PATIENTS WITH TYPE 2 DIABETIC KIDNEY DISEASE: A MULTICENTER DOUBLE-BLINDED RANDOMIZED PLANCEBO-CONTROLLED TRIAL[J].NEPHROLOGY.2014,19:47-47.
APA：
Li Ping,Chen Yiping,Liu Jianping,Hong Jing,Deng Yueyi...&Yang Wenying.(2014).EFFECTS OF TANGSHEN FORMULA ON PATIENTS WITH TYPE 2 DIABETIC KIDNEY DISEASE: A MULTICENTER DOUBLE-BLINDED RANDOMIZED PLANCEBO-CONTROLLED TRIAL.NEPHROLOGY,19,
MLA：
Li Ping,et al."EFFECTS OF TANGSHEN FORMULA ON PATIENTS WITH TYPE 2 DIABETIC KIDNEY DISEASE: A MULTICENTER DOUBLE-BLINDED RANDOMIZED PLANCEBO-CONTROLLED TRIAL".NEPHROLOGY 19.(2014):47-47
